What is Springtide Child Development?
Headquartered in New York City, Springtide Child Development operates as a multi-site clinical practice dedicated to providing comprehensive therapeutic interventions for children facing developmental challenges. The organization distinguishes itself through a multidisciplinary approach, integrating evidence-based practices to improve patient outcomes. As the demand for high-quality, accessible pediatric developmental care continues to rise, Springtide has established itself as a critical player in the healthcare landscape, effectively bridging the gap between clinical research and community-based service delivery.
How much funding has Springtide Child Development raised?
Springtide Child Development has raised a total of $18.1M across 1 funding round:
Series A
$18.1M
Series A (2020): $18.1M with participation from Deerfield Communications Inc and Optum Ventures
Key Investors in Springtide Child Development
Optum Ventures
Optum Ventures is a strategic investment firm focused on early-stage companies that aim to disrupt the healthcare status quo and improve patient outcomes.
Deerfield Communications Inc
A private investment entity providing capital support to high-growth enterprises within the healthcare and communications sectors.
What's next for Springtide Child Development?
With the successful closure of this financing round, Springtide is expected to prioritize the scaling of its physical infrastructure and the expansion of its proprietary care coordination platforms. The strategic focus will likely shift toward increasing market penetration in key urban centers while optimizing patient intake and treatment efficacy. By aligning with institutional backers, the company is well-positioned to navigate the complexities of the healthcare regulatory environment and sustain its momentum as a leader in pediatric developmental health services.
See full Springtide Child Development company page
